
This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/N-Methyl-Cyclazodone: Difference between revisions
Jump to navigation
Jump to search
>Carphknight m Further dosing edit |
>Carphknight m Red color |
||
(32 intermediate revisions by 2 users not shown) | |||
Line 35: | Line 35: | ||
<!-- Structure --> | <!-- Structure --> | ||
|MolecularStructureCaption= | |MolecularStructureCaption= | ||
|SkeletalImageFile=File: | |SkeletalImageFile=File:N-methylcyclazodone.svg | ||
|SkeletalImageWidth=245px | |SkeletalImageWidth=245px | ||
|3DImageFile= | |3DImageFile= | ||
Line 47: | Line 47: | ||
<!-- Class Membership --> | <!-- Class Membership --> | ||
|EffectClass=[[psychoactive class::Stimulant]] | |EffectClass=[[psychoactive class::Stimulant]] | ||
|ChemicalClass=[[chemical class:: | |ChemicalClass=[[chemical class::Substituted aminorexes]] | ||
<!-- Dosage/Duration per ROA --> | <!-- Dosage/Duration per ROA --> | ||
Line 60: | Line 62: | ||
|OralROA_Common=[[Oral min common dose::10]] - [[Oral max common dose::20]] mg | |OralROA_Common=[[Oral min common dose::10]] - [[Oral max common dose::20]] mg | ||
|OralROA_Strong=[[Oral min strong dose::20]] - [[Oral max strong dose::30]] mg | |OralROA_Strong=[[Oral min strong dose::20]] - [[Oral max strong dose::30]] mg | ||
|OralROA_Heavy=[[Oral heavy dose::30]] mg + span style= | |OralROA_Heavy=[[Oral heavy dose::30]] mg + <span style="color:red">'''Liver damage may result from heavy or sustained usage.'''</span> | ||
|OralROA_TimelineFile= | |OralROA_TimelineFile= | ||
|OralROA_TimelineWidth= | |OralROA_TimelineWidth= |
Latest revision as of 16:58, 27 December 2021
SubstanceBox/N-Methyl-Cyclazodone | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chemical Nomenclature | |||||||||||||||||||||||||||||||
Common names | N-Methyl-Cyclazodone, N-Cyclopropyl-N-Methylpemoline, NMC | ||||||||||||||||||||||||||||||
Substitutive name | N-Methyl-Cyclazodone | ||||||||||||||||||||||||||||||
Systematic name | 2-(Cyclopropyl(methyl)amino)-5-phenyl-1,3-oxazol-4-one | ||||||||||||||||||||||||||||||
Class Membership | |||||||||||||||||||||||||||||||
Psychoactive class | Stimulant | ||||||||||||||||||||||||||||||
Chemical class | Substituted aminorexes | ||||||||||||||||||||||||||||||
Routes of Administration | |||||||||||||||||||||||||||||||
|